APA (7th ed.) Citation
(2026). Association Between Bimekizumab’s Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II. Dermatology and Therapy.
Chicago Style (17th ed.) Citation
"Association Between Bimekizumab’s Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II." Dermatology and Therapy 2026.
MLA (9th ed.) Citation
"Association Between Bimekizumab’s Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II." Dermatology and Therapy, 2026.
Warning: These citations may not always be 100% accurate.